Abstract:Background Upregulation of cAMP-dependent and cAMP-independent PKA signaling is thought to promote cystogenesis in polycystic kidney disease (PKD). PKA-I regulatory subunit RI α is increased in kidneys of orthologous mouse models. Kidney-specific knockout of RI α upregulates PKA activity, induces cystic disease in wild-type mice, and aggravates it in Pkd1 RC/RC mice. Methods PKA-I activation or inhibition was compared with EPAC activation or PKA-II inhibition using Pkd1 RC/RC metanephric organ cultures. The effect of constitutive PKA (preferentially PKA-I) downregulation in vivo was ascertained by kidney-specific expression of a dominant negative RIαB allele in Pkd1 RC/RC mice obtained by crossing Prkar1α R1αB/WT , Pkd1 RC/RC , and Pkhd1- Cre mice (C57BL/6 background). The effect of pharmacologic PKA inhibition using a novel, selective PRKACA inhibitor (BLU2864) was tested in mIMCD3 3D cultures, metanephric organ cultures, and Pkd1 RC/RC mice on a C57BL/6 × 129S6/Sv F1 background. Mice were sacrificed at 16 weeks of age. Results PKA-I activation promoted and inhibition prevented ex vivo P-Ser133 CREB expression and cystogenesis. EPAC activation or PKA-II inhibition had no or only minor effects. BLU2864 inhibited in vitro mIMCD3 cystogenesis and ex vivo P-Ser133 CREB expression and cystogenesis. Genetic downregulation of PKA activity and BLU2864 directly and/or indirectly inhibited many pro-proliferative pathways and were both protective in vivo . BLU2864 had no detectable on- or off-target adverse effects. Conclusions PKA-I is the main PKA isozyme promoting cystogenesis. Direct PKA inhibition may be an effective strategy to treat PKD and other conditions where PKA signaling is upregulated. By acting directly on PKA, the inhibition may be more effective than or substantially increase the efficacy of treatments that only affect PKA activity by lowering cAMP.

Pkhd1 Gene Silencing May Cause Cell Abnormal Proliferation Through Modulation Of Intracellular Calcium In Autosomal Recessive Polycystic Kidney Disease

The Advances of Polycystin-1

Effect of fibrocystin on the proliferation of kidney cyst epithelial cells in autosomal recessive polycystic kidney disease

A Rare Deep Intronic Mutation of PKHD1 Gene, C.8798-459 C > A, Causes Autosomal Recessive Polycystic Kidney Disease by Pseudoexon Activation

Autosomal Dominant Polycystic Kidney Disease with Ectopic Unilateral Multicystic Dysplastic Kidney

Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.

Inhibition of Pkhd1 May Cause S-Phase Entry Via Mtor Signaling Pathway

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Down-Regulation Of Pkhd1 Induces Cell Apoptosis Through Pi3k And Nf-Kappa B Pathways

Defects of renal tubular homeostasis and cystogenesis in the Pkhd1 knockout

Cyclin-Dependent Kinase 1 Activity is a Driver of Cyst Growth in Polycystic Kidney Disease.

Mosaic PKHD1 in Polycystic Kidneys Caused Aberrant Protein Expression in the Mitochondria and Lysosomes

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

PKHD1 Post‐transcriptionally Modulated by Mir‐365‐1 Inhibits Cell‐cell Adhesion

Protein Phosphatase 1α Interacts with a Novel Ciliary Targeting Sequence of Polycystin‐1 and Regulates Polycystin‐1 Trafficking

Deficiency of geranylgeranyl biphosphate synthase in kidney tubules causes cystic kidney disease

Activation of PIEZO1 Inhibits Kidney Cystogenesis

Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies

EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease

Salt-deficient Diet Exacerbates Cystogenesis in ARPKD Via Epithelial Sodium Channel (Enac)

RNA Helicase P68 Inhibits the Transcription and Post-Transcription of Pkd1 in ADPKD